Zacks: Analysts Anticipate National Health Investors, Inc. (NYSE:NHI) to Post $1.31 EPS

Wall Street analysts predict that National Health Investors, Inc. (NYSE:NHI) will announce earnings per share of $1.31 for the current fiscal quarter, according to Zacks. Two analysts have provided estimates for National Health Investors’ earnings. The highest EPS estimate is $1.41 and the lowest is $1.19. National Health Investors posted earnings per share of $1.42 in the same quarter last year, which indicates a negative year over year growth rate of 7.7%. The firm is expected to report its next earnings results on Monday, November 8th.

On average, analysts expect that National Health Investors will report full year earnings of $5.08 per share for the current financial year, with EPS estimates ranging from $4.75 to $5.28. For the next fiscal year, analysts expect that the firm will post earnings of $5.30 per share, with EPS estimates ranging from $5.01 to $5.59. Zacks Investment Research’s earnings per share calculations are an average based on a survey of sell-side analysts that follow National Health Investors.

National Health Investors (NYSE:NHI) last issued its earnings results on Monday, August 9th. The real estate investment trust reported $0.85 earnings per share for the quarter, missing the consensus estimate of $1.25 by ($0.40). The firm had revenue of $74.33 million during the quarter, compared to analyst estimates of $77.22 million. National Health Investors had a return on equity of 10.04% and a net margin of 48.09%. The business’s revenue for the quarter was down 11.7% on a year-over-year basis. During the same period in the previous year, the company earned $1.46 earnings per share.

A number of research analysts have recently commented on NHI shares. Wells Fargo & Company lowered their price objective on National Health Investors from $74.00 to $72.00 and set an “equal weight” rating on the stock in a report on Friday, July 23rd. BMO Capital Markets raised National Health Investors from an “underperform” rating to a “market perform” rating and set a $71.00 price objective on the stock in a report on Friday, June 18th. Finally, Zacks Investment Research lowered National Health Investors from a “hold” rating to a “sell” rating in a report on Wednesday, June 23rd. Two equities research analysts have rated the stock with a sell rating and five have given a hold rating to the stock. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $71.14.

Shares of NYSE NHI traded up $0.08 during mid-day trading on Thursday, reaching $57.48. 332,908 shares of the company traded hands, compared to its average volume of 305,590. The company has a debt-to-equity ratio of 0.92, a quick ratio of 16.11 and a current ratio of 16.11. The stock has a market cap of $2.64 billion, a PE ratio of 16.83 and a beta of 0.91. The company’s fifty day moving average is $63.53 and its two-hundred day moving average is $68.05. National Health Investors has a fifty-two week low of $53.70 and a fifty-two week high of $78.56.

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 5th. Shareholders of record on Thursday, September 30th will be issued a $0.90 dividend. This represents a $3.60 dividend on an annualized basis and a yield of 6.26%. The ex-dividend date of this dividend is Wednesday, September 29th. National Health Investors’s dividend payout ratio (DPR) is currently 64.29%.

In other National Health Investors news, Director Robert T. Webb bought 1,500 shares of the stock in a transaction on Tuesday, September 14th. The shares were purchased at an average price of $58.00 per share, with a total value of $87,000.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 6.55% of the company’s stock.

Several hedge funds have recently made changes to their positions in the business. Assetmark Inc. lifted its position in shares of National Health Investors by 3.1% in the 1st quarter. Assetmark Inc. now owns 5,326 shares of the real estate investment trust’s stock worth $385,000 after acquiring an additional 162 shares during the period. The Manufacturers Life Insurance Company lifted its position in shares of National Health Investors by 0.7% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 24,089 shares of the real estate investment trust’s stock worth $1,615,000 after acquiring an additional 165 shares during the period. Vident Investment Advisory LLC lifted its position in shares of National Health Investors by 2.5% in the 2nd quarter. Vident Investment Advisory LLC now owns 7,151 shares of the real estate investment trust’s stock worth $479,000 after acquiring an additional 174 shares during the period. American International Group Inc. lifted its position in shares of National Health Investors by 0.8% in the 1st quarter. American International Group Inc. now owns 27,117 shares of the real estate investment trust’s stock worth $1,960,000 after acquiring an additional 211 shares during the period. Finally, Zurcher Kantonalbank Zurich Cantonalbank lifted its position in shares of National Health Investors by 0.8% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 29,826 shares of the real estate investment trust’s stock worth $2,000,000 after acquiring an additional 244 shares during the period. Institutional investors own 63.97% of the company’s stock.

National Health Investors Company Profile

National Health Investors, Inc is a real estate investment trust, which engages in the sale-leaseback, joint-venture, mortgage, and mezzanine financing of senior housing and medical investments. Its portfolio includes lease, mortgage and other note investments in independent living facilities, assisted living facilities, entrance-fee communities, senior living campuses, skilled nursing facilities, specialty hospitals, and medical office buildings.

Featured Article: Fiduciary

Get a free copy of the Zacks research report on National Health Investors (NHI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.